Market Overview:
The global bruxism management market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of bruxism, rising awareness about the condition, and technological advancements in the field of bruxism management. The global bruxism management market can be segmented on the basis of type into drug treatment, dental approaches, and other treatments. The drug treatment segment is expected to account for the largest share of the global bruxism management market in 2018. This segment is expected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. The dental approaches segment is projected to grow at a CAGR of 7% duringthe same period.
Product Definition:
Bruxism management is the practice of preventing and managing bruxism, which is defined as the clenching and grinding of teeth. Bruxism can lead to a number of dental problems, including tooth decay, gum disease, and chipped or cracked teeth. It can also cause pain in the jaw muscles and headaches. Bruxism management may involve behavioral therapies, such as counseling or stress-relief techniques; dental devices, such as mouth guards or braces; or medications, such as muscle relaxants or painkillers.
Drug Treatment:
Drug treatment is the use of drugs to reduce or eliminate unwanted behavior. The main aim of drug treatment in bruxism management is to reduce or control the grinding and teeth grinding (grinding) that causes pain, discomfort, and stress on a daily basis.
Dental Approaches:
Dental Approaches is a new bruxism treatment device that uses dental approach to treat grinding and clenching of teeth. It works by delivering very small electrical shocks to the teeth via gum electrodes. The device was launched in Europe in 2016 and it received CE approval in 2017, which made it eligible for sale across all EU countries.
Application Insights:
Based on application, the market is segmented into hospital, dental clinic and home care setting. Home care settings are expected to register the highest CAGR over the forecast period due to increasing awareness among individuals regarding their Bruxism habits and associated problems. In addition, growing availability of various treatment options for bruxism at home without having to go to a dental clinic or hospital will boost demand in near future.
The dental approach segment held a substantial share in 2017 owing to high prevalence of patients visiting dentists with complaints regarding tooth grinding and clenching jaws. Moreover, rising number of research studies supporting drug-based management as an effective solution for bruxism is expected fuel demand over the forecast period. However, there are few disadvantages associated with drug-based management such as adverse effects & tolerance issues which may hinder market growth in near future.
Regional Analysis:
Europe dominated the global market in 2017. This can be attributed to the presence of high prevalence of bruxism in this region, coupled with a large number of patients seeking treatment for it. According to an article published by The European Federation of Societies for Dental Research (EFSD), in 2016, approximately 50% - 70% population from western countries like Europe and North America suffer from moderate or severe bruxism. Thus, these regions are considered as high risk areas for dental disorders and are expected to witness higher adoption rates over the forecast period.
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period owing to increasing awareness about oral health among people and rising incidence rates associated with various dental conditions such as tooth grinding/bruxism among adults especially females aged 20-40 years old which is more prevalent than males aged 20-30 years old; also known as sex ratio Bruxism: Males vs Females 1:1).
Growth Factors:
- Increasing awareness about Bruxism and its management among people.
- Growing prevalence of stress and anxiety in the society, which is one of the major causes for Bruxism.
- Rising demand for effective and affordable bruxism management therapies and products.
- Availability of a wide range of bruxism management therapies and products in the market catering to different needs of consumers.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bruxism Management Market Research Report
By Type
Drug Treatment, Dental Approaches,
By Application
Hospital, Dental Clinic, Home Care Setting,
By Companies
Eli Lilly, Cadila Pharmaceuticals, GlaxoSmithKline, Pfizer, Roche, Mylan, Teva, Endo International, Mayne Pharma,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Bruxism Management Market Report Segments:
The global Bruxism Management market is segmented on the basis of:
Types
Drug Treatment, Dental Approaches,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Dental Clinic, Home Care Setting,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Cadila Pharmaceuticals
- GlaxoSmithKline
- Pfizer
- Roche
- Mylan
- Teva
- Endo International
- Mayne Pharma
Highlights of The Bruxism Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Treatment
- Dental Approaches
- By Application:
- Hospital
- Dental Clinic
- Home Care Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bruxism Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bruxism management is the process of managing bruxism, which is a common dental problem that can cause pain and damage to teeth. Treatment may include medication, behavioral therapy, or surgery.
Some of the major companies in the bruxism management market are Eli Lilly, Cadila Pharmaceuticals, GlaxoSmithKline, Pfizer, Roche, Mylan, Teva, Endo International, Mayne Pharma.
The bruxism management market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bruxism Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bruxism Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bruxism Management Market - Supply Chain
4.5. Global Bruxism Management Market Forecast
4.5.1. Bruxism Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bruxism Management Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bruxism Management Market Absolute $ Opportunity
5. Global Bruxism Management Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bruxism Management Market Size and Volume Forecast by Type
5.3.1. Drug Treatment
5.3.2. Dental Approaches
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bruxism Management Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bruxism Management Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Dental Clinic
6.3.3. Home Care Setting
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bruxism Management Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bruxism Management Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bruxism Management Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bruxism Management Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bruxism Management Demand Share Forecast, 2019-2026
9. North America Bruxism Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bruxism Management Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bruxism Management Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Dental Clinic
9.4.3. Home Care Setting
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bruxism Management Market Size and Volume Forecast by Type
9.7.1. Drug Treatment
9.7.2. Dental Approaches
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bruxism Management Demand Share Forecast, 2019-2026
10. Latin America Bruxism Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bruxism Management Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bruxism Management Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Dental Clinic
10.4.3. Home Care Setting
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bruxism Management Market Size and Volume Forecast by Type
10.7.1. Drug Treatment
10.7.2. Dental Approaches
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bruxism Management Demand Share Forecast, 2019-2026
11. Europe Bruxism Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bruxism Management Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bruxism Management Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Dental Clinic
11.4.3. Home Care Setting
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bruxism Management Market Size and Volume Forecast by Type
11.7.1. Drug Treatment
11.7.2. Dental Approaches
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bruxism Management Demand Share, 2019-2026
12. Asia Pacific Bruxism Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bruxism Management Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bruxism Management Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Dental Clinic
12.4.3. Home Care Setting
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bruxism Management Market Size and Volume Forecast by Type
12.7.1. Drug Treatment
12.7.2. Dental Approaches
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bruxism Management Demand Share, 2019-2026
13. Middle East & Africa Bruxism Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bruxism Management Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bruxism Management Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Dental Clinic
13.4.3. Home Care Setting
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bruxism Management Market Size and Volume Forecast by Type
13.7.1. Drug Treatment
13.7.2. Dental Approaches
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bruxism Management Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bruxism Management Market: Market Share Analysis
14.2. Bruxism Management Distributors and Customers
14.3. Bruxism Management Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Eli Lilly
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cadila Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mylan
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Endo International
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mayne Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
